J&J Expands Russian OTC Foothold Via J.B. Chemicals Portfolio Acquisition
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson expands its consumer health presence in Russia and other Eastern European markets with the acquisition of several OTC brands from J.B. Chemicals & Pharmaceuticals.
You may also be interested in...
J&J Cites Neutrogena Among 20 Product Launches Planned For 2015
CEO Alex Gorsky says “20 key product launches” are targeted for 2015, including extensions of the Neutrogena Hydro Boost skin-care and Listerine Healthy White mouthwash lines. Skin care propelled U.S. growth of 2.5% in J&J’s consumer-health business during the fourth quarter, the firm reported.
J&J Includes Listerine In 20 Consumer Product Launches Planned In 2015
CEO Alex Gorsky says “20 key product launches” are planned for 2015, including extensions for the Listerine Healthy White mouthwash Neutrogena Hydro Boost skin care lines. Analgesics and upper respiratory products drive global OTC sales growth in the fourth quarter.
J&J Includes Listerine In 20 Consumer Product Launches Planned In 2015
CEO Alex Gorsky says “20 key product launches” are planned for 2015, including extensions for the Listerine Healthy White mouthwash Neutrogena Hydro Boost skin care lines. Analgesics and upper respiratory products drive global OTC sales growth in the fourth quarter.